Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Concepción Montón"'
Autor:
Ester Cuevas, Daniel Huertas, Concepción Montón, Alicia Marin, Anna Carrera-Salinas, Xavier Pomares, Marian García-Nuñez, Sara Martí, Salud Santos
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundContinuous treatment with azithromycin may lead to fewer acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but little is known of its impact on systemic and functional outcomes in real-life settings.MethodsThis was a mu
Externí odkaz:
https://doaj.org/article/076ca5f8444340d384e4e0960e68abe1
Autor:
Laura Millares, Sergi Pascual, Concepción Montón, Marian García-Núñez, Cristina Lalmolda, Rosa Faner, Carme Casadevall, Laia Setó, Silvia Capilla, Amàlia Moreno, Ady Angélica Castro-Acosta, Carlos José Alvarez-Martinez, Oriol Sibila, Germán Peces-Barba, Borja G. Cosio, Alvar Agustí, Joaquim Gea, Eduard Monsó
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils,
Externí odkaz:
https://doaj.org/article/a568107fbe3c4613b078ece0b4c21c5a
Autor:
Marian Garcia-Nuñez, Miguel Garcia-Gonzalez, Xavier Pomares, Concepción Montón, Laura Millares, Sara Quero, Elena Prina, Oscar Asensio, Montserrat Bosque, Silvia Capilla, Oscar Cuevas, Eduard Monsó
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
We compared the bacterial microbiomes lodged in the bronchial tree, oropharynx and nose of patients with early stage cystic fibrosis (CF) not using chronic antibiotics, determining their relationships with lung function and exacerbation frequency. CF
Externí odkaz:
https://doaj.org/article/cb5b15316f7d44f0b02fd41c20335c51
Autor:
Laura Millares, Vicente Pérez-Brocal, Rafaela Ferrari, Miguel Gallego, Xavier Pomares, Marian García-Núñez, Concepción Montón, Silvia Capilla, Eduard Monsó, Andrés Moya
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144448 (2015)
The course of chronic obstructive pulmonary disease (COPD) is frequently aggravated by exacerbations, and changes in the composition and activity of the microbiome may be implicated in their appearance. The aim of this study was to analyse the compos
Externí odkaz:
https://doaj.org/article/532e1f2285434bd5964d37dce96bbdab
Autor:
Eduard Monsó, Jose R Cugat, Xavier Pomares, Concepción Montón, Antonio Casabella, Elena Prina, Joan Carles Oliva, Miguel Gallego
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2365-2373
Introduction Long-term use of nebulized or oral antibiotics is common in the treatment of cystic fibrosis and non-cystic fibrosis bronchiectasis. To date, however, few studies have focused on the use of nebulized antibiotics in COPD patients. The aim
Autor:
Joaquim Gea, Sergi Pascual, Ady Castro-Acosta, Carmen Hernández-Carcereny, Robert Castelo, Eduardo Márquez-Martín, Concepción Montón, Alexandre Palou, Rosa Faner, Laura I. Furlong, Luis Seijo, Ferran Sanz, Montserrat Torà, Carles Vilaplana, Carme Casadevall, José Luis López-Campos, Eduard Monsó, Germán Peces-Barba, Borja G. Cosío, Alvar Agustí, Mireia Admetlló, Carlos Alvarez-Martínez, Esther Barreiro, Ferran Casals, Rocío Córdova, Marian García, José G. González-García, Eduardo Márquez, Miren Josune Ormaza, Pau Puigdevall, Luis Seijó, Yolanda Torralba
Publikováno v:
Archivos de Bronconeumología (English Edition). 55:93-99
Chronic obstructive pulmonary disease (COPD) is an entity with a heterogeneous presentation. For this reason, attempts have been made to characterize different phenotypes and endotypes to enable a more individualized approach. The aim of the Biomarke
Autor:
Xavier Pomares, Antonio Casabella, Sara Martí, Ester Cuevas, Alicia Marin, Concepción Montón, Joan Carles Oliva, Daniel Huertas, Salud Santos
Publikováno v:
Respiration; international review of thoracic diseases. 100(11)
Background: Long-term azithromycin therapy significantly reduces the frequency of COPD exacerbations (ECOPD). However, previous studies have used different dosing regimens, and the efficacy of these regimens has not been compared. Objective: Compare
Autor:
Silvia Capilla, Xavier Pomares, Vicente Pérez-Brocal, Andrés Moya, Eduard Monsó, Mateu Espasa, Miguel Gallego, Marian Garcia-Nuñez, Concepción Montón, Laura Millares, Rafaella Ferrari
Publikováno v:
FUTURE VIROLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Aim: To characterize the respiratory virome in moderate/severe chronic obstructive pulmonary disease (COPD) patients using metagenomics, with healthy subjects as the reference. Patients & Methods: Sputum COPD samples were collected during stability a
Autor:
Xavier Pomares, Eduard Monsó, Concepción Montón, Miguel Gallego, Oscar Cuevas, Joan Carles Oliva, Miriam Bullich
Publikováno v:
Chest. 153:1125-1133
Background Exacerbations of COPD (ECOPD) are a major cause of mortality and morbidity. Continuous cyclic azithromycin (CC-A) reduces the exacerbation rate, but it is unknown whether it remains effective and safe beyond the first year. Methods This st
Autor:
María José Amengual, Concepción Montón, Xavier Pomares, Christian Domingo, Rosa Mirapeix, Albert Navarro, Ana Sogo
Publikováno v:
British Journal of Clinical Pharmacology. 84:339-348
Aims There are no specific criteria for a step-down or withdrawal dose of omalizumab (OMA). Our purpose was to evaluate the viability of a protocol for OMAlizumab DOse REduction (the OMADORE study) in severe allergic asthma (SAA). Methods The study p